ArticleAntioxidants (Basel, Switzerland)2022

TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment.

Grazia Scandura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.